Apf/Cbp, An Anionic Polypeptide in Bile and Gallstones That May Regulate Calcium Salt and Cholesterol Precipitation From Bile
1992; Lippincott Williams & Wilkins; Volume: 16; Issue: 6 Linguagem: Inglês
10.1002/hep.1840160627
ISSN1527-3350
Autores Tópico(s)Gallbladder and Bile Duct Disorders
ResumoHepatologyVolume 16, Issue 6 p. 1493-1496 EditorialFree Access APF/CBP, an anionic polypeptide in bile and gallstones that may regulate calcium salt and cholesterol precipitation from bile J. Donald Ostrow M.D., Corresponding Author J. Donald Ostrow M.D. D.V.A. Lakeside Medical Center Chicago, Illinois 60611Medical Investigator, Research Service (151), D.V.A. Lakeside Medical Center, 400 East Ontario Street, Chicago, IL 60611===Search for more papers by this author J. Donald Ostrow M.D., Corresponding Author J. Donald Ostrow M.D. D.V.A. Lakeside Medical Center Chicago, Illinois 60611Medical Investigator, Research Service (151), D.V.A. Lakeside Medical Center, 400 East Ontario Street, Chicago, IL 60611===Search for more papers by this author First published: December 1992 https://doi.org/10.1002/hep.1840160627Citations: 18AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Kestell MF, Sekijima J, Lee SP, Park HZ, Long M, Kaler EW. A calcium binding protein in bile and gallstones. HEPATOLOGY 1992; 16: 1315– 1321. 2 Nalbone G, Lafont H, Vigne JL, Domingo N, Lairon D, Chabert C, Lechene P, et al. The apoprotein fraction of the bile lipoprotein complex: isolation, partial characterization and phospholipid binding properties. Biochimie 1985; 61: 1029– 1041. 3 Martigne M, Domingo N, Lafont H, Nalbone G, Hauton JC. Purification of the human anionic polypeptide fraction of the apo-bile lipoprotein complex by zonal ultracentrifugation. Lipids 1985; 20: 884– 889. 4 Shimizu S, Sabsay B, Veis A, Ostrow JD, Rege RV, Dawes LG. Isolation of an acidic protein from cholesterol gallstones which inhibits the precipitation of calcium carbonate in vitro. J Clin Invest 1989; 84: 1990– 1996. 5 Okido M, Shimizu S, Ostrow JD, Nakayama F. Isolation of a calcium-regulatory protein from black pigment gallstones: similarity with a protein from cholesterol gallstones. HEPATOLOGY 1992; 15: 1079– 1085. 6 Ostrow JD. Unconjugated bilirubin and cholesterol gallstone formation. HEPATOLOGY 1990; 12 (suppl 97): 219S– 226S. 7 Ostrow JD, Celic L. Apparent solubility products (K&'sp) of the calcium salts of unconjugated bilirubin (B) indicate supersaturation of human gallbladder bile with Ca(HB)2, but not CaB [Abstract]. HEPATOLOGY 1987; 7: 1111. 8 Vadali M, Ostrow JD, Mukerjee P, Celic L. Aqueous solubility products of calcium bilirubinate salts, determined by solvent partition from chloroform into buffer aqueous solutions of CaCl2. In: Proceedings of the XII International Bile Acid Meeting. Basel: 1992. 9 Shiffman ML, Sugerman HJ, Moore EW. Human mucosal gallbladder function: effect of concentration and acidification of bile on cholesterol and calcium solubility. Gastroenterology 1990; 99: 1452– 1459. 10 Knyrim K, Vakil N. The effects of synthetic human secretin on calcium carbonate solubility in human bile. Gastroenterology 1990; 99: 1445– 1451. 11 Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile: relationship to gallstone formation and dissolution in man. J Clin Invest 1978; 61: 998– 1026. 12 Moore EW. Biliary calcium and gallstone formation. HEPATOLOGY 1990; 12 (suppl 97): 206S– 218S. 13 Crowther RS, Soloway RD. Pigment gallstone pathogenesis: from man to molecules. Semin Liver Dis 1990; 10: 171– 180. 14 Holzbach RT. Recent progress in understanding cholesterol crystal nucleation as a precursor to human gallstone formation. HEPATOLOGY 1986; 6: 1403– 1406. 15 Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE. Biliary proteins: unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984; 73: 35– 45. 16 Burnstein JM, Ilson RG, Petrunka CN, Strasberg SM. Evidence for a potent nucleation factor in gallbladder bile of patients with cholesterol gallstones. Gastroenterology 1983; 85: 801– 807. 17 Levy PF, Smith BF, Lamont JT. Human gallbladder mucin accelerates in vitro nucleation of cholesterol in artificial bile. Gastroenterology 1984; 87: 270– 275. 18 Groen AK, Noordam C, Drapers JAG, Egbers P, Jansen PLM, Tytgat GNJ. Isolation of a potent cholesterol nucleationpromoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. HEPATOLOGY 1990; 11: 525– 533. 19 Harvey PRC, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991; 266: 13996– 14003. 20 Groen AK. Nonmucous glycoproteins as pronucleating agents. HEPATOLOGY 1990; 12 (suppl 97): 189S– 194S. 21 Busch N, Holzbach RT. Crystal growth-inhibiting proteins in bile. HEPATOLOGY 1990; 12 (suppl 97): 195S– 199S. 22 Schwarzendrube J, Nuutinen H, Abei N, Chandler K, Williams C, Holzbach RT. Amino acid sequencing and immunological localization of a unique 120 kD dimeric crystal growth-inhibiting biliary glycoprotein [Abstract]. Gastroenterology 1992; 102: A882. 23 Gallinger S, Harvey PRC, Petrunka CN, Strasberg SM. Effect of binding of ionized calcium on the in vitro nucleation of cholesterol and calcium bilirubinate in human gallbladder bile. Gut 1986; 27: 1382– 1386. 24 Shermak MA, Lipsett PA, Kaufman HS, Fox-Talbot MK, Pitt HA, Lillemoe KD. Calcium interacts with biliary proteins to induce cholesterol crystal nucleation [Abstract]. Gastroenterology 1992; 102: A941. 25 Sutor DJ, Percival JM. Presence or absence of inhibitors of crystal growth in bile. 1. Effect of bile on the formation of calcium phosphate, a constituent of gallstones. Gut 1976; 17: 506– 510. 26 Sutor DJ, Percival JM. The effect of bile on the crystallization of calcium carbonate. Clin Chim Acta 1978; 89: 479– 484. 27 Sciaretta A, Ligabue A, Garuti G, Pieromaldi S, Verri I, Giacobazzi G, Malaguti P. Inhibitory activity of gallbladder bile on calcium carbonate crystallization in vitro: a comparison between normal subjects and gallstone patients. Scand J Gastroenterol 1984; 19: 626– 630. 28 Dawes LG, Moore EW, Rege RV, Shimizu S, Ostrow JD. Canine bile contains anticrystallization factors that inhibit precipitation of calcium carbonate. HEPATOLOGY 1991; 14: 701– 706. 29 Shimizu S, Sabsay B, Veis A, Ostrow JD, Dawes LG, Rege RV. A 12-kDa acidic protein from cholesterol gallstones inhibits precipitation of calcium carbonate and is present in human bile [Abstract]. HEPATOLOGY 1988; 8: 1257. 30 Lafont H, Ostrow JD, Shimizu S, Domingo N, Lechéne P, Hauton JC, Rege RV, et al. Are anionic polypeptide fraction (APF) from bile and calcium-binding protein (CBP) from gallstones identical [Abstract]? Gastroenterology 1991; 100: A764. 31 Domingo N, Grosclaude J, Bekaert ED, Mege D, Chapman MJ, Shimizu S, Ayrault-Jarrier M, et al. Epitope mapping of the human biliary amphipathic anionic polypeptide (APF): similarity with a calcium-binding protein (CBP) isolated from gallstones and bile, and immunological cross-reactivity with apolipoprotein A-I. J Lipid Res 1992; 33: 1419– 1430. 32 Martigne M, Domingo N, Lechene de la Porte P, Lafont H, Hauton JC. Identification and localization of apoprotein fraction of the bile lipoprotein complex in human gallstones. Scand J Gastroenterol 1988; 23: 731– 737. 33 Domingo N, Groen B, Lechéne P, de Bruijn M, Ostrow JD, Lafont H. Anionic polypeptide fraction (APF) avidly interacts with cholesterol/lecithin vesicles and promotes crystal growth in model bile [Abstract]. Gastroenterology 1992; 102: A802. 34 Trotman BW, Rajagopalan C, Bernstein SE. Monoconjugated bilirubin is a major component of hemolysis-induced gallstones in mice. HEPATOLOGY 1988; 8: 919– 924. 35 Veis A. Bones and teeth. In: KA Piez, H Reddi, eds. Extracellular matrix biochemistry. New York: Elsevier/North Holland Publishers, 1984: 329– 374. 36 Sömjen GJ, Gilat T. A non-micellar mode of cholesterol transport in bile. FEBS Lett 1983; 156: 265– 268. 37 Ulloa N, Garrido J, Nervi F. Ultracentrifugal isolation of vesicular carriers of biliray cholesterol in native human and rat bile. HEPATOLOGY 1987; 7: 235– 244. 38 Marteau C, Portugal H, Pauli AM, Gerolami A. Effect of glycoursodeoxycholate on precipitation of calcium carbonate. HEPATOLOGY 1985; 5: 1209– 1212. 39 Van der Meer R, DeVries HT. Differential binding of glycine- and taurine-conjugated bile acids to insoluble calcium phosphate. Biochem J 1985; 229: 265– 268. 40 Qui SM, Wen G, Hirakawa N, Soloway RD, Hong NK, Crowther RS. Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite. J Clin Invest 1991; 88: 1265– 1271. 41 Nancollas GH. Crystallization in bile. HEPATOLOGY 1984; 4 (suppl): 169S– 172S. 42 Veis A, Sabsay B. Bone and tooth formation: insights into mineralization strategies. In: P Westbroek, EW De Jong, eds. Biomineralization and biological metal accumulation: biological and geological. Dordrecht, The Netherlands: D. Riedel Co., 1982: 273– 284. 43 Sabsay B, Stetler-Stevenson WG, Lechner JH, Veis A. Domain structure and sequence distribution in dentin phosphophoryn. Biochem J 1991; 276: 699– 707. 44 Nakagawa Y, Ahmed M, Hall SL, DeGanello S, Coe FL. Isolation from human calcium oxalate renal stones of a glycoprotein inhibitor of calcium oxalate crystal growth: evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in γ-carboxyglutamic acid. J Clin Invest 1987; 79: 1782– 1787. 45 DeCaro A, Multigner L, Lafont H, Lombardo D, Sarles H. The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth. Biochem J 1984; 222: 669– 677. 46 Smith BF, Lamont JT. Hydrophobic binding properties of bovine gallbladder mucin. J Biol Chem 1984; 259: 12170– 12177. 47 Sanabria JR, Upadhya GA, Harvey PRC, Strasberg SM. Diffusion of substances into cholesterol gallstones [Abstract]. Gastroenterology 1992; 102: A878. 48 Martigne M, Meli B, Mahlberg F, Domingo N, Chanussot F, Lafont H, Hauton JC. Detection and characterization of anionic polypeptidic fraction binding sites in rat liver plasma membranes and cultured hepatocytes. Biochim Biophys Acta 1989; 979: 341– 346. 49 Martigne M, Domingo N, Chanussot F, Nalbone G, Lafont H, Hauton J. Effects of bile anionic polypeptide fraction on the fate of cholesterol carried by liposomes in the rat. Proc Soc Exp Biol Med 1988; 187: 229– 234. 50 Domingo N, Botta D, Martigne-Cros M, Lechene de la Porte P, Pak-Leung P, Hauton J, Lafont H. Evidence for the synthesis and secretion of APF–a bile lipid associated protein–by isolated rat hepatocytes. Biochim Biophys Acta 1990; 1044: 243– 248. 51 Chanussot F, Domingo N, Tuchweber B, Lafont H, Yousef IB. Influence of dehydrocholic and cholic acids infusions on the biliary secretion of anionic polypeptide fraction, the major apoprotein of the biliary lipoprotein complex. Scand J Gastroenterol 1992; 27: 238– 242. 52 DeBruijn MAC, Mok K, Domingo N, Lafont H, Tytgat GNJ, Groen AK. Further characterization of the cholesterol crystallization promoting lipoprotein in biliary Con-A–binding protein [Abstract]. Gastroenterology 1992; 102: A310. Citing Literature Volume16, Issue6December 1992Pages 1493-1496 ReferencesRelatedInformation
Referência(s)